10 research outputs found
No effect of encapsulation on the pharmacokinetics of warfarin
- Author
- Bates
- Bredberg
- Colwell
- Da Silva
- Eriksson
- Eriksson
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Francis
- Francis
- Ginsberg
- Gustafsson
- Hignite
- Hirsh
- Kelly
- Kim
- King
- Kong
- Milliken
- O'Reilly
- Palareti
- Pinede
- Sarich
- Sarich
- Sarich
- Schulman
- Teng
- The Executive Steering Committee on behalf of the SPORTIF V Investigators
- Toon
- Wallentin
- Yacobi
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textPharmacologic Strategies for the Prevention of Stroke in Patients With Atrial Fibrillation
- Author
- A Laupacis
- BI Eriksson
- BI Eriksson
- C Gustafsson
- D Feng
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Greg Flaker
- GY Lip
- GYH Lip
- H Asakura
- J Heeringa
- J Stangier
- JN Fiessinger
- K Kumagai
- L Wallentin
- L Wallentin
- RG Hart
- Richard Weachter
- S Connolly
- S Kamath
- S Kamath
- S Shulman
- SJ Connolly
- SJ Connolly
- SPORTIF Executive Steering Committee for the SPORTIF V Investigators
- T Sadangara
- The AMADEUS Investigators
- The Direct Thrombin Inhibitors Investigators
- The Executive Steering Committee on behalf of the ROCKET AF Study Investigators
- The RE-MOBILIZE Writing committee
- WM Feinberg
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full textSome Thoughts on Challenges for Noninferiority Study Designs
- Author
- A Koch
- CIBIS-II InvestigatorsCommittees
- Executive Steering Committee on Behalf of the SPORTIF-III Investigators
- HM Hung
- J Schumi
- JA Berlin
- JHM Hung
- JP Siegel
- LM Friedman
- M Packer
- M Packer
- R DerSimonian
- R Temple
- RB D’Agostino Sr
- S Kaul
- S Kaul
- S Thackray
- S Yusuf
- SJ Pocock
- SPORTIF Executive Steering Committee for the SPORTIF-V Investigators
- SS Ellenberg
- The BEST Steering Committee
- The CAPRICORN Investigators
- The International Steering Committee on Behalf of the MERIT-HF Study Group
- The ONTARGET Investigators
- TR Fleming
- TR Fleming
- V Hasselblad
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
No full textTranscatheter occlusion of the left atrial appendage for stroke prevention
- Author
- Blackshear
- Bonow
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Fischer
- Gage
- Gage
- Go
- Hart
- Hart
- Horst Sievert
- Katz
- Madden
- Meier
- Ostermayer
- Sandercock
- Sick
- Sievert
- SPORTIF Executive SteeringCommittee for the SPORTIF V Investigators
- Stafford
- Stefan H Ostermayer
- The Stroke Preventionin Atrial Fibrillation Investigators Committee on Echocardiography
- Veinot
- Wolf
- Yves L Bayard
- Publication venue
- 'Informa UK Limited'
- Publication date
- Field of study
No full textXimelagatran: An Oral Direct Thrombin Inhibitor
- Author
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
No full textXimelagatran: A New Antithrombotic Option in Atrial Fibrillation
- Author
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
No full textNew aspects on treatment modalities for thromboembolic episodes
- Author
- Anderson
- Aujesky
- Aujesky
- Barritt
- Belcaro
- Bjorholt
- Brandjes
- Buller
- Büller
- Büller
- Büller
- Connolly
- De Luca
- Eikelboom
- Elsharawy
- Enden
- Enden
- Eriksson
- Eriksson
- Eriksson
- Fiessinger
- Ginsberg
- Gross
- Harenberg
- Hirsh
- Ho
- Huisman
- Kakkar
- Kangelaris
- Kearon
- Kearon
- Kishimoto
- Koopman
- Kubitza
- Kubitza
- Lassen
- Lassen
- Lassen
- Levine
- Lopes
- Olsson
- Paty
- PERSIST Investigators
- Pineo
- Pradaxa
- Raghavan
- Righini
- ROCKET AF Study Investigators
- Rosenbeck-Hansen
- Schulman
- Schulman
- Schulman
- Stangier
- The Amadeus Investigators
- The Executive Steering Committee on behalf of the SPORTIF V Investigators
- Turpie
- Turpie
- Van Dongen
- Van Dongen
- Veyrat-Follet
- Watson
- Weitz
- Wells
- Wolowacz
- Wolowacz
- Yusuf
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textBleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management
- Author
- Agnelli
- Albers
- Ansell
- Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group
- Antithrombotic Trialists’ Collaboration
- Bauer
- Berkowitz
- Bertrand
- Brandjes
- Bredberg
- Brouwer
- Buckingham
- Cairns
- Campbell
- Colwell
- Colwell
- Committee for Proprietary Medicinal Products European Agency for the Evaluation of Medicinal Products
- Connolly
- Consensus Development Conference
- Crowther
- Dahl
- Dahl
- EAFT (European Atrial Fibrillation Trial) Study Group
- Elg
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Es
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Ezekowitz
- Fihn
- Fihn
- Fitzgerald
- Francis
- Francis
- Francis
- Fuster
- Geerts
- Gottlieb
- Graafsma
- Gullov
- Halperin
- Heit
- Heit
- Hellemons
- Herault
- Hirsh
- Hirsh
- Hull
- Hull
- Hull
- Hull
- Hull
- Hull
- Hull
- Hull
- Hurlen
- Hurlen
- Hyers
- Hylek
- Johansson
- Johansson
- Keam
- Kearon
- Kearon
- Kirchmaier
- Klement
- Koopman
- Landefeld
- Landefeld
- Landefeld
- Lassen
- Launbjerg
- Lebrazi
- Leclerc
- Leclerc
- Levine
- Levine
- Lindmarker
- Lopaciuk
- Petersen
- Planes
- Prandoni
- Rao
- Ridker
- Sarich
- Sarich
- Schulman
- Schulman
- Schulman
- Simonneau
- Smith
- Stroke Prevention in Atrial Fibrillation Investigators
- Stroke Prevention in Atrial Fibrillation Investigators
- Stroke Prevention in Atrial Fibrillation Study
- Task Force on Pulmonary Embolism European Society of Cardiology
- The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
- The Columbus Investigators
- The Executive Steering Committee on behalf of the SPORTIF V Investigators
- The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group
- Turpie
- Turpie
- Van de Werf
- Verheugt
- Wallentin
- Weitz
- Weitz
- Wolzt
- Wåhlander
- Yusuf
- Yusuf
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textNew approaches to anticoagulation in atrial fibrillation
- Author
- AK Malik
- AR Tabrizi
- AS Go
- Atrial Fibrillation Investigators
- B Dahlback
- B Polack
- BI Eriksson
- BI Eriksson
- BI Eriksson
- BI Eriksson
- CJL Murray
- CW Colwell
- CW Colwell
- CW Francis
- CW Francis
- D Gustafsson
- DE Singer
- DS Conway
- DS Conway
- DS Conway
- E Bredberg
- EAFT (European Atrial Fibrillation Trial) Study Group
- EM Hylek
- EM Hylek
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Executive Steering Committee on behalf of the SPORTIF V investigators
- GW Albers
- H Eriksson
- HC Evans
- J Ansell
- J Hirsh
- J Hirsh
- JA Heit
- JH Gurwitz
- JL Halperin
- K Wåhlander
- K Wåhlander
- LA Harker
- LC Johansson
- LC Johansson
- LK Gottlieb
- M Elg
- M Elg
- M Wolzt
- M Wolzt
- MN Levine
- P Petersen
- PA Wolf
- Palle Petersen
- RG Hart
- RH Falk
- S Kamath
- S Kamath
- S Kamath
- S Schulman
- SR Kahn
- TC Sarich
- TC Sarich
- TJ Bungard
- U Eriksson
- UG Eriksson
- UG Eriksson
- V Fuster
- WM Feinberg
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full textFacts and Principles Learned at the 31st Annual Williamsburg Conference on Heart Disease
- Author
- Abidov A
- Allman KC
- Amanullah AM
- Antman EM
- Armstrong PW
- Baumgartner H
- Bax JJ
- Bello D
- Benjamin EJ
- Berman DS
- Bonow RO
- Bristow MR
- Brown BG
- Buxton AE
- Bänsch D
- Calnon DA
- CAPRIE Steering Committee
- Celermajer DS
- Cohn JN
- Dakik HA
- DeSouza CA
- Dickstein K
- Enriquez-Sarano M
- Executive Steering Committee on behalf of the SPORTIF III Investigators
- Felker GM
- Foot DK
- Franklin SS
- Fuster V
- Galassi AR
- Galassi AR
- Garg R
- Garg R
- Georghiade M
- Gibson PB
- Giri S
- Haas F
- Hachamovitch R
- Hachamovitch R
- Hall SA
- Hunt SA
- Iskander S
- James WPT
- Javaheri S
- Jones DW
- Khan NE
- Kim RJ
- Kirchhof P
- Klein C
- Knowler WC
- Kostis JB
- Lee I-M
- Lee KL
- Levy D
- Lewington S
- Lloyd-Jones DM
- Mann DL
- Mehta SR
- Meluzin J
- Moss AJ
- Moss AJ
- Nieto FJ
- Nissen SE
- Oler A
- Oral H
- Pagley PR
- Pappone C
- Pappone C
- Peppard PE
- Petersen P
- Pfeffer MA
- Pfeffer MA
- Pitt B
- Pitt B
- Poole-Wilson PA
- Poston WSC
- Pu M
- Rahimtoola SH
- Redfield MM
- Sagie A
- Shamsuzzaman ASM
- Sharir T
- Siebelink H-MJ
- Spertus JA
- Staessen JA
- Steinberg HO
- Steinhubl SR
- Stevenson WG
- Suwaidi JA
- Tchernof A
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
- The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators
- The Direct Thrombin Inhibitor Trialists' Collaborative Group
- Thourani VH
- Tsang TSM
- Tuomilehto J
- Uretsky BF
- Van Gelder IC Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM
- Vasan RS
- Vasan RS
- Yusuf S
- Zheng Z-J
- Zile MR
- Zipes DP
- Publication venue
- 'Informa UK Limited'
- Publication date
- Field of study
No full text
